13/02/2013

Report no. 21/2013

Amendment to a significant contract in the subsidiary company “Mikulicz” sp. z o.o. in Świebodzice

 

 
Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A., in connection with receiving as of 13 February 2013 a contract concluded with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) signed by the subsidiary company “Mikulicz” sp. z o.o. regarding healthcare services in the scope of  hospital treatment –health programmes (pharmaceutical programmes) for the period from 1 January to 31 December 2013.
 
Healthcare services referred to hereinabove are provided by the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned by EMC Instytut Medyczny S.A.
 
The Issuer informed about the contracts concluded by Mikulicz sp. z o.o. with the Fund Branch concerning rendering  healthcare services in 2013 in its current report no. 17/2013 of 05.02.2013.
 
As a result of signing the said contract, the total maximum Fund Branch liability towards the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned  by the Issuer  currently amounts to PLN  14,654,917.00 (an increase by PLN 548,971.00) for healthcare services rendered in the period from 1 January to 31 December 2013.
 The other material terms of the contract with the highest value made public remain unchanged.
 
 A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital